ANN FORDE: Open Payments
NPI 1710953724 · STERLING HEIGHTS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,148 in 112 payments from 27 companies in 2025. Trend: 2023 $1,564 · 2024 $2,338 · 2025 $2,148
Food & beverage: $2,148
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $254 |
| Mannkind Corporation | 15 | $211 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $198 |
| Amgen Inc. | 16 | $178 |
| Xeris Pharmaceuticals, Inc. | 8 | $143 |
| Medtronic, Inc. | 1 | $130 |
| Corcept Therapeutics | 5 | $118 |
| Neurocrine BioSciences, Inc. | 4 | $104 |
| Ascendis Pharma Endocrinology Inc | 4 | $89 |
| ABBVIE INC. | 4 | $82 |
Products named: AFREZZA, JARDIANCE, TEPEZZA, MINIMED 780G, Ozempic, Korlym, CRENESSITY, GVOKE HYPOPEN.
Industry payments across MI — which companies pay providers there.
